Correlation analysis between PD-L1 expression, TMB and clinical characteristics in Chinese non-small cell lung cancer

被引：1
|
作者：
Yu, Yang [1 ]
Fan, Xinglong [2 ]
Wei, Yucheng [3 ]
Liu, Zimin [3 ]
Lian, Zuping [4 ]
Han, Hongxia [5 ]
Yao, Ming [5 ]
Wang, Kai [5 ,6 ]
机构：
[1] Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
[2] Qilu Hosp, Qingdao Branch, Qingdao, Shandong, Peoples R China
[3] Qingdao Univ, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[4] Guangxi Univ Chinese Med, Ruikang Hosp, Nanning, Peoples R China
[5] OrigiMed, Shanghai, Peoples R China
[6] Zhejiang Univ Int Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4056
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Concomitant PD-L1 Expression and Driver Oncogenes in Non-small Cell Lung Cancer
    McNeill, N.
    Horton, J. J.
    Freitas, T. A.
    Shiller, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1003 - 1003
  • [42] PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations
    Scheel, Andreas H.
    Ansen, Sascha
    Schultheis, Anne M.
    Scheffler, Matthias
    Fischer, Rieke N.
    Michels, Sebastian
    Hellmich, Martin
    George, Julie
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry
    Timens, Wim
    Perner, Sven
    von Bergwelt-Baildon, Michael
    Buettner, Reinhard
    Wolf, Juergen
    ONCOIMMUNOLOGY, 2016, 5 (05):
  • [43] Effect of neoadjuvant chemoimmunotherapy on PD-L1 expression in non-small cell lung cancer
    Stoykova, S.
    Chriqui, L.
    Berchtold, E. Abdelnour
    Peters, S.
    Perentes, J. Y.
    Berezowska, S.
    VIRCHOWS ARCHIV, 2024, 485 : S20 - S20
  • [44] PD-L1 Expression and its Correlation with Tumor TNM Stage in Patients with Non-Small Cell Lung Cancer
    Jang, T.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S532 - S532
  • [45] Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients
    Tokito, Takaaki
    Azuma, Koichi
    Ishii, Hidenobu
    Yamada, Kazuhiko
    Hoshino, Tomoaki
    ANNALS OF ONCOLOGY, 2015, 26 : 97 - 97
  • [46] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [47] Clinical Characteristics of Acquired Resistance with Anti-PD-1/PD-L1 in Non-Small Cell Lung Cancer (NSCLC)
    Shah, Shalin
    Wood, Kevin
    Brisson, Ryan
    Karrison, Theodore
    Hensing, Thomas
    Luke, Jason J.
    Patel, Jyoti D.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S310 - S310
  • [48] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [49] Correlative analysis of gene expression changes and PD-L1 immunoexpression in non-small cell lung cancer
    Guerreiro, I. M. C.
    Barros-Silva, D.
    Lopes, P.
    Cunha, A. L.
    Lobo, J.
    Rodrigues, A.
    Soares, M.
    Antunes, L.
    Henrique, R.
    Jeronimo, C.
    ANNALS OF ONCOLOGY, 2018, 29 : 5 - 5
  • [50] Prognostic value of PD-L1 expression in non-small cell lung cancer: a meta-analysis
    Fan, Yangwei
    Ma, Ke
    Hu, Yuan
    Niu, Wenxia
    Li, Enxiao
    Wu, Yinying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (06): : 8735 - +
12345